The Journal of Immunology, Vol 154, Issue 3 1273-1279, Copyright © 1995 by American Association of Immunologists

ARTICLES

Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences

A Neisig, J Roelse, AJ Sijts, F Ossendorp, MC Feltkamp, WM Kast, CJ Melief and JJ Neefjes
Department of Immunohematology and Blood Bank, University Hospital, Leiden, The Netherlands.

The MHC-encoded transporter associated with Ag presentation (TAP) translocates peptides from the cytosol to the ER lumen, where association with MHC class I molecules occurs. The MHC class I/peptide complex is subsequently transported to the cell surface for presentation to CD8+T cells. We studied TAP-dependent translocation of defined MHC class I presentable murine peptides by competition for translocation of a radiolabeled model peptide, to address whether efficient peptide presentation by MHC class I molecules is preceded by equal efficient peptide translocation by TAP. Surprisingly, we observed that four immunodominant viral peptides of 16 peptides tested were very inefficiently transported by TAP. Inefficient translocation could be overcome by substitution of a proline residue present at position 3 in the peptides. Furthermore, addition of natural flanking amino acids directly surrounding a poorly transported peptide could considerably improve translocation by TAP. Our data suggest that some peptides are efficiently transported by TAP in their optimal size for MHC class I binding, whereas other peptides are transported as larger peptide fragments that need further trimming in the ER for MHC class I binding.

This article has been cited by other articles:

				C. F. Towne, I. A. York, L. B. Watkin, J. S. Lazo, and K. L. Rock Analysis of the Role of Bleomycin Hydrolase in Antigen Presentation and the Generation of CD8 T Cell Responses J. Immunol., June 1, 2007; 178(11): 6923 - 6930. [Abstract] [Full Text] [PDF]

				G. G. M. Pinkse, O. H. M. Tysma, C. A. M. Bergen, M. G. D. Kester, F. Ossendorp, P. A. van Veelen, B. Keymeulen, D. Pipeleers, J. W. Drijfhout, and B. O. Roep Autoreactive CD8 T cells associated with {beta} cell destruction in type 1 diabetes PNAS, December 20, 2005; 102(51): 18425 - 18430. [Abstract] [Full Text] [PDF]

				P. Otahal, S. C. Hutchinson, L. M. Mylin, M. J. Tevethia, S. S. Tevethia, and T. D. Schell Inefficient Cross-Presentation Limits the CD8+ T Cell Response to a Subdominant Tumor Antigen Epitope J. Immunol., July 15, 2005; 175(2): 700 - 712. [Abstract] [Full Text] [PDF]

				R. Draenert, S. Le Gall, K. J. Pfafferott, A. J. Leslie, P. Chetty, C. Brander, E. C. Holmes, S.-C. Chang, M. E. Feeney, M. M. Addo, et al. Immune Selection for Altered Antigen Processing Leads to Cytotoxic T Lymphocyte Escape in Chronic HIV-1 Infection J. Exp. Med., April 5, 2004; 199(7): 905 - 915. [Abstract] [Full Text] [PDF]

				P. Rueda, G. Moron, J. Sarraseca, C. Leclerc, and J. I. Casal Influence of flanking sequences on presentation efficiency of a CD8+ cytotoxic T-cell epitope delivered by parvovirus-like particles J. Gen. Virol., March 1, 2004; 85(3): 563 - 572. [Abstract] [Full Text] [PDF]

				Y. Samino, D. Lopez, S. Guil, P. de Leon, and M. Del Val An Endogenous HIV Envelope-derived Peptide without the Terminal NH3+ Group Anchor Is Physiologically Presented by Major Histocompatibility Complex Class I Molecules J. Biol. Chem., January 9, 2004; 279(2): 1151 - 1160. [Abstract] [Full Text] [PDF]

				D. M. Koelle, Z. Liu, C. L. McClurkan, R. C. Cevallos, J. Vieira, N. A. Hosken, C. A. Meseda, D. C. Snow, A. Wald, and L. Corey Immunodominance among herpes simplex virus-specific CD8 T cells expressing a tissue-specific homing receptor PNAS, October 28, 2003; 100(22): 12899 - 12904. [Abstract] [Full Text] [PDF]

				E. Spierings, A. G. Brickner, J. A. Caldwell, S. Zegveld, N. Tatsis, E. Blokland, J. Pool, R. A. Pierce, S. Mollah, J. Shabanowitz, et al. The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein Blood, July 15, 2003; 102(2): 621 - 629. [Abstract] [Full Text] [PDF]

				R. F. Rich and W. R. Green Characterization of the Fas Ligand/Fas-Dependent Apoptosis of Antiretroviral, Class I MHC Tetramer-Defined, CD8+ CTL by In Vivo Retrovirus-Infected Cells J. Immunol., March 15, 2002; 168(6): 2751 - 2758. [Abstract] [Full Text] [PDF]

				R. A. Pierce, E. D. Field, T. Mutis, T. N. Golovina, C. V. Kap-Herr, M. Wilke., J. Pool, J. Shabanowitz, M. J. Pettenati, L. C. Eisenlohr, et al. The HA-2 Minor Histocompatibility Antigen Is Derived from a Diallelic Gene Encoding a Novel Human Class I Myosin Protein J. Immunol., September 15, 2001; 167(6): 3223 - 3230. [Abstract] [Full Text] [PDF]

				C. A. Herberts, K. J. Stittelaar, E. van der Heeft, J. van Gaans-van den Brink, M. C. M. Poelen, P. J. M. Roholl, L. J. W. van Alphen, C. J. M. Melief, A. P. J. M. de Jong, and C. A. C. M. van Els A measles virus glycoprotein-derived human CTL epitope is abundantly presented via the proteasomal-dependent MHC class I processing pathway J. Gen. Virol., September 1, 2001; 82(9): 2131 - 2142. [Abstract] [Full Text] [PDF]

				C. Knuehl, P. Spee, T. Ruppert, U. Kuckelkorn, P. Henklein, J. Neefjes, and P.-M. Kloetzel The Murine Cytomegalovirus pp89 Immunodominant H-2Ld Epitope Is Generated and Translocated into the Endoplasmic Reticulum as an 11-Mer Precursor Peptide J. Immunol., August 1, 2001; 167(3): 1515 - 1521. [Abstract] [Full Text] [PDF]

				S. Weijzen, S. C. Meredith, M. P. Velders, A. G. Elmishad, H. Schreiber, and W. M. Kast Pharmacokinetic Differences Between a T Cell-Tolerizing and a T Cell-Activating Peptide J. Immunol., June 15, 2001; 166(12): 7151 - 7157. [Abstract] [Full Text] [PDF]

				M. P. Velders, S. Weijzen, G. L. Eiben, A. G. Elmishad, P.-M. Kloetzel, T. Higgins, R. B. Ciccarelli, M. Evans, S. Man, L. Smith, et al. Defined Flanking Spacers and Enhanced Proteolysis Is Essential for Eradication of Established Tumors by an Epitope String DNA Vaccine J. Immunol., May 1, 2001; 166(9): 5366 - 5373. [Abstract] [Full Text] [PDF]

				A. G. Brickner, E. H. Warren, J. A. Caldwell, Y. Akatsuka, T. N. Golovina, A. L. Zarling, J. Shabanowitz, L. C. Eisenlohr, D. F. Hunt, V. H. Engelhard, et al. The Immunogenicity of a New Human Minor Histocompatibility Antigen Results from Differential Antigen Processing J. Exp. Med., January 8, 2001; 193(2): 195 - 206. [Abstract] [Full Text] [PDF]

				T. van Hall, A. Sijts, M. Camps, R. Offringa, C. Melief, P.-M. Kloetzel, and F. Ossendorp Differential Influence on Cytotoxic T Lymphocyte Epitope Presentation by Controlled Expression of Either Proteasome Immunosubunits or PA28 J. Exp. Med., August 14, 2000; 192(4): 483 - 494. [Abstract] [Full Text] [PDF]

				Q.-J. Zhang, S. S. Chen, C.-A. Saari, M. G. Massuci, F. Tufaro, and W. A. Jefferies Evidence of Selective Processing of Immunodominant Epitopes in Virally Infected Cells J. Immunol., May 1, 2000; 164(9): 4513 - 4521. [Abstract] [Full Text] [PDF]

				V. Kim, J. W. Yewdell, and W. R. Green Naturally Occurring TAP-Dependent Specific T-Cell Tolerance for a Variant of an Immunodominant Retroviral Cytotoxic T-Lymphocyte Epitope J. Virol., April 15, 2000; 74(8): 3924 - 3928. [Abstract] [Full Text]

				N. J. Beekman, P. A. van Veelen, T. van Hall, A. Neisig, A. Sijts, M. Camps, P.-M. Kloetzel, J. J. Neefjes, C. J. Melief, and F. Ossendorp Abrogation of CTL Epitope Processing by Single Amino Acid Substitution Flanking the C-Terminal Proteasome Cleavage Site J. Immunol., February 15, 2000; 164(4): 1898 - 1905. [Abstract] [Full Text] [PDF]

				M. Lucchiari-Hartz, P. M. van Endert, G. Lauvau, R. Maier, A. Meyerhans, D. Mann, K. Eichmann, and G. Niedermann Cytotoxic T Lymphocyte Epitopes of HIV-1 Nef: Generation of Multiple Definitive Major Histocompatibility Complex Class I Ligands by Proteasomes J. Exp. Med., January 17, 2000; 191(2): 239 - 252. [Abstract] [Full Text] [PDF]

				C. Brander, O. O. Yang, N. G. Jones, Y. Lee, P. Goulder, R. P. Johnson, A. Trocha, D. Colbert, C. Hay, S. Buchbinder, et al. Efficient Processing of the Immunodominant, HLA-A*0201-Restricted Human Immunodeficiency Virus Type 1 Cytotoxic T-Lymphocyte Epitope despite Multiple Variations in the Epitope Flanking Sequences J. Virol., December 1, 1999; 73(12): 10191 - 10198. [Abstract] [Full Text]

				G. Lauvau, K. Kakimi, G. Niedermann, M. Ostankovitch, P. Yotnda, H. Firat, F. V. Chisari, and P. M. van Endert Human Transporters Associated with Antigen Processing (TAPs) Select Epitope Precursor Peptides for Processing in the Endoplasmic Reticulum and Presentation to T Cells J. Exp. Med., November 1, 1999; 190(9): 1227 - 1240. [Abstract] [Full Text] [PDF]

				J. S. Haurum, I. B. Hoier, G. Arsequell, A. Neisig, G. Valencia, J. Zeuthen, J. Neefjes, and T. Elliott Presentation of Cytosolic Glycosylated Peptides by Human Class I Major Histocompatibility Complex Molecules In Vivo J. Exp. Med., July 5, 1999; 190(1): 145 - 150. [Abstract] [Full Text] [PDF]

				T. Serwold and N. Shastri Specific Proteolytic Cleavages Limit the Diversity of the Pool of Peptides Available to MHC Class I Molecules in Living Cells J. Immunol., April 15, 1999; 162(8): 4712 - 4719. [Abstract] [Full Text] [PDF]

				S. Daniel, V. Brusic, S. Caillat-Zucman, N. Petrovsky, L. Harrison, D. Riganelli, F. Sinigaglia, F. Gallazzi, J. Hammer, and P. M. van Endert Relationship Between Peptide Selectivities of Human Transporters Associated with Antigen Processing and HLA Class I Molecules J. Immunol., July 15, 1998; 161(2): 617 - 624. [Abstract] [Full Text] [PDF]

				J. K. Sandberg, P. Grufman, E. Z. Wolpert, L. Franksson, B. J. Chambers, and K. Karre Superdominance Among Immunodominant H-2Kb-Restricted Epitopes and Reversal by Dendritic Cell-Mediated Antigen Delivery J. Immunol., April 1, 1998; 160(7): 3163 - 3169. [Abstract] [Full Text] [PDF]

				T.-M. Fu, L. M. Mylin, T. D. Schell, I. Bacik, G. Russ, J. W. Yewdell, J. R. Bennink, and S. S. Tevethia An Endoplasmic Reticulum-Targeting Signal Sequence Enhances the Immunogenicity of an Immunorecessive Simian Virus 40 Large T Antigen Cytotoxic T-Lymphocyte Epitope J. Virol., February 1, 1998; 72(2): 1469 - 1481. [Abstract] [Full Text] [PDF]

				A. Neisig, C. J. M. Melief, and J. Neefjes Reduced Cell Surface Expression of HLA-C Molecules Correlates with Restricted Peptide Binding and Stable TAP Interaction J. Immunol., January 1, 1998; 160(1): 171 - 179. [Abstract] [Full Text] [PDF]

				M. P.M. Vierboom, H. W. Nijman, R. Offringa, E. I.H. v. d. Voort, T. v. Hall, L. v. d. Broek, G. J. Fleuren, P. Kenemans, W. M. Kast, and C. J.M. Melief Tumor Eradication by Wild-type p53-specific Cytotoxic T Lymphocytes J. Exp. Med., August 29, 1997; 186(5): 695 - 704. [Abstract] [Full Text] [PDF]

				S. Uebel, W. Kraas, S. Kienle, K.-H. Wiesmuller, G. Jung, and R. Tampe Recognition principle of the TAP transporter disclosed by combinatorial peptide libraries PNAS, August 19, 1997; 94(17): 8976 - 8981. [Abstract] [Full Text] [PDF]

				G. Russ, F. Esquivel, J. W. Yewdell, P. Cresswell, T. Spies, and J. R. Bennink Assembly, Intracellular Localization, and Nucleotide Binding Properties of the Human Peptide Transporters TAP1 and TAP2 Expressed by Recombinant Vaccinia Viruses J. Biol. Chem., September 8, 1995; 270(36): 21312 - 21318. [Abstract] [Full Text] [PDF]

				A. Komlosh, F. Momburg, T. Weinschenk, N. Emmerich, H. Schild, E. Nadav, I. Shaked, and Y. Reiss A Role for a Novel Luminal Endoplasmic Reticulum Aminopeptidase in Final Trimming of 26 S Proteasome-generated Major Histocompatability Complex Class I Antigenic Peptides J. Biol. Chem., August 3, 2001; 276(32): 30050 - 30056. [Abstract] [Full Text] [PDF]